Published April 9, 2010 | Version v1
Journal article

Structural insights into mouse anti-apoptotic Bcl-xl reveal affinity for Beclin 1 and gossypol

  • 1. University of Science and Technology, 305-333 Gawak-Ro, Yusong-Gu, Daejeon (Korea, Republic of)
  • 2. Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 136-701 (Korea, Republic of)
  • 3. Biomedical Research Center, KIST (Korea, Republic of)
  • 4. Centre for Neural Sciences, KIST, Seoul 136-791 (Korea, Republic of)

Description

This study reports the crystal structures of Bcl-xl wild type and three Bcl-xl mutants (Y101A, F105A, and R139A) with amino acid substitutions in the hydrophobic groove of the Bcl-xl BH3 domain. An additional 12 ordered residues were observed in a highly flexible loop between the α1 and α2 helices, and were recognized as an important deamidation site for the regulation of apoptosis. The autophagy-effector protein, Beclin 1, contains a novel BH3 domain (residues 101-125), which binds to the surface cleft of Bcl-xl, as confirmed by nuclear magnetic resonance (NMR) spectroscopy and analytical gel-filtration results. Gossypol, a potent inhibitor of Bcl-xl, had a Kd value of 0.9 μM. In addition, the structural and biochemical analysis of five Bcl-xl substitution mutants will provide structural insights into the design and development of anti-cancer drugs.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2010.03.002

Additional details

Identifiers

DOI
10.1016/j.bbrc.2010.03.002;
PII
S0006-291X(10)00425-0;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
394
Journal Issue
3
Journal Page Range
p. 515-521
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.